Sponsor pipeline

Dwight Owen clinical trial pipeline

4 active trials 3 recruiting 3 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-08-19

Trial completed
Completion moved earlier: 2026-10-31 → 2025-12-02

NCT03728361 Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell… · Phase 2

2026-08-07

Primary completion moved earlier: 2027-04-30 → 2026-07-17

NCT03463460 Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or… · Phase 2

Phase 1		2
Phase 2		2

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT04919382	Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or…	Extensive Stage Lung Small Cell Carcinoma	Recruiting	2026-04-08
NCT03463460	Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or…	Thymic Carcinoma	Active, Not Recruiting	2026-08-06
Phase 1
NCT06616623	Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell…	Metastatic Lung Non-Small Cell Carcinoma	Recruiting	2026-02-27
NCT05234307	PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung…	Metastatic Lung Non-Small Cell Carcinoma	Recruiting	2026-02-06

Get alerts when Dwight Owen's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.